[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 24, Issue 2 (4-2019) ::
__Armaghane Danesh__ 2019, 24(2): 274-292 Back to browse issues page
Materials and Metabolites of Kynureinine Pathway in Neurodegenerative Diseases and Multiple Sclerosis
M Rostaminejad 1, A Rostaminejad2 , T Kalantari3
1- Department of Laboratory Sciences, Shiraz University of Medical Sciences, Shiraz, Iran , taherehk@yahoo.com
2- Department of Anesthesiology, Yasuj University of Medical Sciences, Yasuj, Iran,
3- Diagnostic Laboratory Sciences and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract:   (3352 Views)


Background & aim: Kynurenine pathway (KP) plays an important role in the pathogenesis of neuroinflammation and neurodegenerative disorders. In neurodegenerative diseases (NDD) such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD) and Multiple sclerosis (MS), brain neurons are initially involved and gradually disappear. In the present review article, the role and effect of changes in the balance of Kinorin pathway metabolites in the process of exacerbation of neurodegenerative and MS diseases will be discussed.


Methods: The present review study applied various databases to collect all research reports which had been conducted in recent years to study and evaluate the Kinorenic pathways and metabolites in neurodegenerative and MS.


Results: Regarding the prevalence and importance of these diseases, there is an urgent need to develop new and more effective therapeutic strategies to fight these destructive diseases. One of the molecular pathways, along with the metabolites derived from it in all of the diseases, is the Kinorenic Path. The effect of the Kinorenic pathway on many diseases, including neurodegenerative and MS is observed in all of which imbalances in the levels of tryptophan and its metabolites. That is, if the amount of Kin Orin pathway metabolites is returned to the normal range, it will reduce the symptoms of the disease, while a change in the balance of these metabolites, seen in neurodegenerative diseases and MS, will worsen and progress the disease.


Conclusion: Kinorenin is known as an important determinant of immune responses and tolerance in T cells. In this case, it seems that the destruction of tryptophan and the production of a number of downstream metabolic pathways of Kin Orin, a disruption of protein synthesis, and the suppression of the production and proliferation of T cells is regulated in favor of diseases such as MS.


Keywords: Kynurenine Pathway, Neurodegenerative Diseases, Multiple Sclerosis, MS, Parkinson's Disease, Alzheimer's Disease, IDO1
Full-Text [PDF 4273 kb]   (657 Downloads)    
Type of Study: Review Article | Subject: Immunology
Received: 2018/10/16 | Accepted: 2019/05/14 | Published: 2019/05/19
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rostaminejad M, Rostaminejad A, Kalantari T. Materials and Metabolites of Kynureinine Pathway in Neurodegenerative Diseases and Multiple Sclerosis. ارمغان دانش. 2019; 24 (2) :274-292
URL: http://armaghanj.yums.ac.ir/article-1-2314-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 2 (4-2019) Back to browse issues page
ارمغان دانش Armaghane Danesh
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4410